| 21-012 |
Juan Pablo Atal, Jose Ignacio Cuesta, Felipe Gonzalez, Cristobal Otero |
The Economics of the Public Option: Evidence from Local Pharmaceutical Markets |
| 20-009 |
Juan Pablo Atal, Hanming Fang, Martin Karlsson, Nicolas Ziebarth |
Long-Term Health Insurance: Theory Meets Evidence |
| 20-016 |
Jorge Alé-Chilet, Juan Pablo Atal, Patricio Domínguez |
Activity and the incidence of emergencies: Evidence from daily data at the onset of a pandemic |
| 19-017 |
Juan Pablo Atal, Jose Ignacio Cuesta, Morten Sæthre |
Quality Regulation and Competition: Evidence from Pharmaceutical Markets |
| 19-020 |
Juan Pablo Atal |
Lock-in in Dynamic Health Insurance Contracts: Evidence from Chile |
| 17-012 |
Juan Pablo Atal, Hanming Fang, Martin Karlsson, Nicolas Ziebarth |
Exit, Voice or Loyalty? An Investigation into Mandated Portability of Front-Loaded Private Health Plans |
